Together these findings indicate that the receptor TIE2 is of clinical significance in breast cancer and that a high TIE2 expression could be a marker for a good prognosis as it is associated with a slower progression of the disease, which could be due to induction of dormancy. Here, TEK is linked to breast carcinoma.